Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Market Cap	28.60M
Revenue (ttm)	n/a
Net Income (ttm)	-2.18M
Shares Out	168.26M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	301,063
Average Volume	156,717
Open	0.1700
Previous Close	0.1650
Day's Range	0.1600 - 0.1750
52-Week Range	0.0400 - 0.3600
Beta	0.87
RSI	36.10
Earnings Date	Jul 28, 2025

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Brent Willis
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VM